Pharmacists exporting sacubitril/valsartan should consider indirect impact on patient safety
I wish to highlight an ongoing problem to the readers of The
Pharmaceutical Journal with shortages of one of our newer heart failure treatments sacubitril/valsartan.
Heart failure (HF) is the most malignant form of heart disease and has outcomes comparable with most common cance…